Akhil Rasim Reddy
Interventional Cardiology · Aurora, CONPI 1447644075
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (44.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 68.0% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $17,259 and has fallen 92.5% since, to $1,291 in 2025.
Across 205 payments — averaging $141.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$20K
- Edwards Lifesciences$5K
- Abbott$1K
- Boston Scientific$685
- Penumbra, Inc.$387
- Inari Medical, Inc.$360
- plus $1K from 18 others
What the payments were for
- Grants$13,00045%
- Travel & lodging$9,10931%
- Food & beverage$6,70223%
- Education$2001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 78 | $19,734 |
| Edwards Lifesciences | 54 | $5,469 |
| Abbott | 15 | $1,087 |
| Boston Scientific | 19 | $685 |
| Penumbra, Inc. | 3 | $387 |
| Inari Medical, Inc. | 3 | $360 |
| AstraZeneca | 6 | $279 |
| Shockwave Medical, Inc | 1 | $206 |
| Abiomed | 4 | $170 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $157 |
| Novo Nordisk | 2 | $140 |
| Cvrx, Inc. | 2 | $43 |
| Amgen | 3 | $43 |
| Scpharmaceuticals Inc. | 2 | $36 |
| Alnylam Pharmaceuticals Inc. | 1 | $35 |
| W. L. Gore & Associates, Inc. | 2 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Heartflow, Inc. | 1 | $22 |
| Cleerly, Inc. | 1 | $21 |
| Bridgebio Pharma, Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Merck | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$13,729
- Resolute$1,861
- RESOLUTE ONYX$1,581
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,575
- PASCAL$1,264
- MitraClip$801
- Indigo System$387
- FLOWTRIEVER CATHETER, S$342
- CT THROMBECTOMY SYSTEM KIT$342
- Onyx$308
- GENERAL - THERAPIES$254
- ONYX 18$209
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$206
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$186
- LifeVest$135
- SAPIEN 3 Ultra RESILIA$122
How this compares
$29,011 in reported general payments places this provider in the 75th percentile of 111 interventional cardiology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 12 | $154 |
| Atorvastatin Calcium | 19 | $108 |
| Lisinopril | 13 | $19 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Aurora
- Gareth MorganAurora$536K
- Jamaluddin MolooAurora$272K
- Jenny Zablah AlabiAurora$269K
- Sridhar Sampath-KumarAurora$142K
- Matthew ZipseAurora$137K
- Jeffrey ParkAurora$132K
- John CarrollAurora$25K
- Connie HessAurora$19K
- Aken DesaiAurora$19K
- Neel ButalaAurora$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.